[Form 4] Avantor, Inc. Insider Trading Activity
Avantor, Inc. (AVTR) SVP & Chief Accounting Officer Steven W. Eck reported an equity grant in the form of 31,645 restricted stock units on April 3, 2026, which vest in three equal annual installments beginning April 3, 2027. This transaction, categorized as a compensation grant rather than an open-market purchase, increased his direct holdings to 130,978 shares of Avantor common stock. The Form 4 filing indicates a neutral impact and sentiment regarding this insider activity.
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Avantor, Inc. announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. The company will also host a conference call to discuss these results at 8:00 a.m. Eastern Daylight Time on the same day. Investors can access a live audio webcast and a replay on Avantor's investor relations website.
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates
This article provides details on Avantor, Inc.'s Q1 earnings, which met analyst estimates. It highlights key financial figures and performance metrics from the quarter.
Avantor to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Avantor, Inc. (NYSE: AVTR) announced it will release its first quarter 2026 financial results before market open on Wednesday, April 29, 2026. The company will also host a conference call to discuss these results at 8:00 a.m. Eastern Daylight Time on the same day. A live audio webcast will be available on Avantor's investor relations website, with a replay accessible for 30 days.
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Avantor, Inc. (NYSE: AVTR) announced it will release its first quarter 2026 financial results before market open on Wednesday, April 29, 2026. The company will also host a conference call on the same day at 8:00 a.m. Eastern Daylight Time to discuss these results. A live audio webcast of the session and its replay will be available on Avantor's investor relations website.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into Avantor, Inc. (AVTR) regarding potential corporate wrongdoing involving its officers and/or directors. The firm is encouraging shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them for more information and to assist with the investigation. The firm operates on a contingency fee basis, meaning no cost to investors unless the investigation is successful.
SG Americas Securities LLC Acquires 272,093 Shares of Avantor, Inc. $AVTR
SG Americas Securities LLC significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 209.5% in the fourth quarter, purchasing 272,093 additional shares to bring its total holding to 401,969 shares. This move, valued at $4.607 million, is complemented by accelerated insider buying, with directors acquiring 275,000 shares worth nearly $2.4 million. Despite a "Hold" consensus rating and a target price of $11.80 against a current trading price near $7.77, the company reported a slight EPS beat and issued FY2026 EPS guidance, indicating cautious optimism from some investors.
Avantor finance chief exits; Steve Eck to step in as interim CFO
Avantor (NYSE: AVTR) announced that CFO R. Brent Jones will depart the company by June 24, 2026, with Senior VP and Chief Accounting Officer Steve Eck stepping in as interim CFO. The company has initiated a search for a permanent CFO and reaffirmed its fiscal 2026 guidance, which was previously provided on February 11, 2026. This transition comes amidst Avantor's ongoing turnaround efforts and recent strategic changes.
AVANTOR INC - REAFFIRMS FISCAL 2026 FINANCIAL GUIDANCE
Avantor Inc. has reaffirmed its financial guidance for fiscal year 2026. This announcement indicates the company's confidence in its projected performance and strategic direction. Investors and market observers will be watching to see how the company aligns with these reaffirmed targets.
Avantor, Inc. Announces CFO Transition in April 2026 Press Release
Avantor, Inc. announced that its Executive Vice President and Chief Financial Officer, R. Brent Jones, will depart on or before June 24, 2026, to join a company outside the life sciences industry. Steven Eck, the current Senior Vice President and Chief Accounting Officer, has been appointed interim CFO while the company searches for a permanent replacement. Avantor also reaffirmed its fiscal 2026 financial guidance.
Avantor stock holds at Market Perform as CFO departs, guidance intact
William Blair has maintained a Market Perform rating on Avantor Inc. (NYSE:AVTR) after the announcement of CFO Brent Jones' departure, with the company reiterating its 2026 guidance despite the executive change and previous guidance cuts. The stock has been under pressure, trading near its 52-week low, but analysis suggests it may be undervalued. This transition follows a recent CEO change and the launch of a new turnaround program.
Avantor stock holds at Market Perform as CFO departs, guidance intact
William Blair maintained a Market Perform rating on Avantor Inc. (AVTR) after the announcement of CFO Brent Jones' departure, noting the company's 2026 guidance remains intact despite previous cuts and executive changes. The stock has fallen significantly, but InvestingPro analysis suggests it may be undervalued. This transition follows a recent CEO change and the launch of a turnaround program, while Avantor also recently reported mixed Q4 2025 results.
How Investors Are Reacting To Avantor (AVTR) CFO Succession and Interim Finance Leadership Shift
Avantor (AVTR) has announced that its CFO, R. Brent Jones, will depart the company by June 24, 2026, with Steve Eck serving as interim CFO. This transition is seen as maintaining continuity rather than causing disruption, but it highlights existing challenges for Avantor, including stabilizing margins, achieving earnings growth, and managing leverage. Investors will focus on how the new permanent CFO balances shareholder returns, such as the recently completed share repurchase program, with the need for deleveraging amidst ongoing pricing pressures and bioprocessing headwinds.
R. Brent Jones to Leave as Executive Vice President of Avantor, Inc., Effective on or Before June 24, 2026
Avantor, Inc. announced that Executive Vice President R. Brent Jones will depart from the company on or before June 24, 2026. This news comes amidst other recent appointments to Avantor's committees and board, and follows recent financial performance reports and analyst adjustments to price targets.
Avantor Announces CFO Resignation and Interim Finance Leadership
Avantor (AVTR) announced that its CFO, R. Brent Jones, resigned on March 26, 2026, to pursue an opportunity outside the life sciences sector. Steven Eck, the Senior Vice President and Chief Accounting Officer, will serve as interim CFO during the search for a permanent successor and will receive increased compensation and a restricted stock unit award for his expanded role. Avantor's stock currently holds a "Hold" rating from analysts with a $7.50 price target, while TipRanks' AI Analyst, Spark, rates AVTR as "Neutral" due to weakening fundamentals and conservative guidance.
Avantor (AVTR) plans CFO change, names interim finance chief and reaffirms 2026 guidance
Avantor, Inc. (AVTR) announced that its Executive Vice President and CFO, R. Brent Jones, will depart on or before June 24, 2026. Steve Eck, current Senior Vice President and Chief Accounting Officer, will serve as interim CFO during the search for a permanent successor. The company also reaffirmed its previously issued fiscal year 2026 financial guidance.
Avantor’s Stubblefield Talks Innovation, Sustainability With Axios
Avantor CEO Michael Stubblefield was interviewed by Axios to discuss the company's innovation business model and steadfast commitment to sustainability. Stubblefield emphasized that sustainability is crucial for Avantor's operations and highlighted their collaborative efforts across the value chain, including a Responsible Supplier Program and the adoption of technologies to reduce waste such as automated packaging systems. The interview also touched on Avantor's recent sustainability report which outlines their positive impact on the environment and society.
Avantor CFO R. Brent Jones to depart by late June
Avantor Inc. announced that its CFO, R. Brent Jones, will depart by late June 2026. This news follows a 50% decline in the company's shares over the past year. Steve Eck, the current SVP and Chief Accounting Officer, will serve as interim CFO, and the company has reaffirmed its fiscal 2026 financial guidance.
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) on behalf of investors who purchased securities prior to March 5, 2024, and continue to hold them. The investigation aims to determine if Avantor and its officers engaged in corporate wrongdoing. The law firm is encouraging affected investors to contact them to assist with the investigation, with no cost to the investors as they operate on a contingency fee basis.
Avantor, Inc. Hits New 52-Week Low at $7.27 Amidst Declining Performance
Avantor, Inc. (a small-cap specialty chemicals company) has hit a new 52-week low of $7.27, with its stock price plummeting by 68.43% over the past year. The company is facing significant financial challenges, including a 58.83% decline in net profit and an operating profit margin of 15.02%, raising concerns about its long-term fundamental strength. Its performance has consistently lagged behind the S&P 500, indicating ongoing struggles in the competitive market.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE:AVTR) securities who bought shares prior to March 5, 2024, and continue to hold them. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing. Investors are encouraged to contact the law firm to assist with the investigation, with no cost to them as the firm operates on a contingency fee basis.
Is Avantor (AVTR) Now Offering Value After A 54% One Year Share Price Decline
Avantor (AVTR) has experienced a significant 54% decline in its share price over the past year, leading to questions about its current valuation. According to Simply Wall St's analysis, Avantor appears undervalued based on both a Discounted Cash Flow (DCF) model, which suggests a 52% undervaluation, and its Price/Sales (P/S) ratio of 0.77x, which is significantly lower than its industry peers and its estimated Fair Ratio. Investors are encouraged to consider these valuation methods and their own narratives to assess the stock's future potential.
[ARS] Avantor, Inc. SEC Filing
This article announces an SEC filing (Form ARS) for Avantor, Inc. (AVTR), indicating a neutral sentiment and low impact. The filing was accepted on March 27, 2026, at 7:48 AM UTC. Avantor is ranked by market cap, with a current market cap of $5.23 billion.
Form DEFA14A Avantor, Inc.
Avantor, Inc. has filed Form DEFA14A with the United States Securities and Exchange Commission, indicating a definitive additional materials filing under Schedule 14A. This filing pertains to a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. No fee was required for this filing.
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks
The ongoing war in Iran and the disruption of the Strait of Hormuz are significantly impacting petrochemical supply chains, which could lead to increased costs for medical supplies within weeks. Analysts indicate that derivatives like naphtha and methanol, crucial for pharmaceutical packaging and drug ingredients, are seeing price surges and supply chain pressure. While an immediate shortage of medical supplies is not expected, hospitals may face higher procurement costs for essential items like IV bags and sterile tubing within 30 to 60 days if the disruption persists.
Avantor (NYSE:AVTR) Reaches New 12-Month Low - Time to Sell?
Avantor (NYSE:AVTR) recently hit a new 52-week low of $7.38, well below its consensus target and moving averages, despite beating Q1 earnings estimates with $0.22 EPS and $1.66 billion revenue. The company is facing mixed analyst ratings, with downgrades and target cuts, and has issued lower-than-analyst-expected FY2026 guidance. However, insider buying, including directors acquiring shares at higher prices, suggests some confidence in the company's future.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (AVTR) regarding corporate wrongdoing. The firm encourages investors who purchased Avantor securities before March 5, 2024, and still hold them, to join their investigation. The law firm represents investors on a contingency fee basis and seeks to restore investor capital and ensure corporate accountability.
Research Alert: CFRA Maintains Hold Rating On Shares Of Avantor
This article is a research alert indicating that CFRA has maintained a Hold rating on shares of Avantor. No additional details are available in the provided content.
EDGAR Filing Documents for 0001628280-25-046936
This article details an EDGAR filing for Avantor, Inc. (CIK: 0001722482), specifically a Form 10-Q (Quarterly report) filed on October 29, 2025, for the period ending September 30, 2025. It lists numerous associated documents, including the HTML version of the 10-Q, various exhibits, and XBRL taxonomy files, along with the company's mailing and business addresses.
Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Drop
Circumference Group invested $3.5 million to acquire 305,000 shares of Avantor (NYSE:AVTR) in the fourth quarter of 2025, constituting 3.77% of their portfolio. This move comes as Avantor's stock has dropped 54% over the past year, despite the company generating significant cash flow and implementing a "Revival" program to address operational inefficiencies. The article suggests that Avantor's stable demand for lab consumables could make it an attractive long-term investment if margins recover.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (AVTR) securities. The firm encourages stockholders who bought Avantor securities before March 5, 2024, and still hold them, to contact them for more information and to assist in the investigation into potential corporate wrongdoing by Avantor and its officers/directors. The firm operates on a contingency fee basis, meaning no upfront cost to investors.
A Look At Avantor (AVTR) Valuation After Prolonged Share Price Weakness
Avantor (AVTR) has seen significant share price weakness, with a 54.46% decline in total shareholder return over the past year. Despite this, Simply Wall St's analysis suggests the stock is undervalued at US$7.51, with a fair value pegged at $10.89 and analysts' consensus price target of $14.118, implying a 51% intrinsic discount. However, investors are advised to consider risks such as pressure on bioprocessing revenue and margin compression.
Circumference Group's New Avantor Investment: A 3.5M Dollar Position - News and Statistics
Circumference Group has invested $3.5 million in Avantor, acquiring 305,000 shares, which represents 3.77% of the firm's reportable assets. Avantor, a provider of laboratory materials and equipment, recently traded at $7.51 per share, experiencing a significant decline over the past year despite reporting annual revenues exceeding $6.5 billion and positive adjusted earnings. The company is actively working on improving its execution and cost structure.
Why a $3.5 Million Wager Focuses on Avantor After a 54% Share Price Decline
Circumference Group has invested $3.5 million in Avantor (NYSE:AVTR) by purchasing 305,000 shares, despite a recent 54% decline in Avantor's stock price over the past year. This investment highlights a potential opportunity for long-term investors, as Avantor generates positive cash flow and is implementing a "Revival" initiative to improve efficiency. The article suggests that successful execution of these strategies could position Avantor as a strong cash flow generator.
Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Drop
Circumference Group has established a new position in Avantor (NYSE:AVTR), acquiring 305,000 shares valued at $3.5 million in the fourth quarter of 2025. This move comes despite Avantor's stock having dropped 54% over the past year, significantly underperforming the S&P 500. The investment highlights a potential long-term play on Avantor's stable demand for lab consumables and its "Revival" program aimed at improving profitability and cash flow.
Avantor Inc stock faces pressure amid weak FY2026 guidance and market selloff
Avantor Inc (ISIN: US05352A1007) is facing significant stock pressure due to a weaker-than-expected FY2026 EPS guidance of $0.77-$0.83, falling short of the $1.06 consensus, and a recent market selloff. The company's Q2 2025 results also missed EPS expectations, driven by softening biopharma demand. Investors, including those in DACH portfolios, are closely monitoring the upcoming Q1 2026 earnings for signs of recovery and improved outlook amidst ongoing macroeconomic uncertainty and R&D spending headwinds.
Avantor, Inc. $AVTR Shares Acquired by Greenhaven Associates Inc.
Greenhaven Associates Inc. significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 12% in the fourth quarter, now holding over 20.5 million shares valued at $234.94 million. Avantor reported better-than-expected quarterly earnings and revenue, while institutional ownership stands at over 95%. Analysts currently have a "Hold" rating on the stock with a consensus target price of $11.80.
Avantor, Inc. (NYSE:AVTR) Given Average Recommendation of "Hold" by Brokerages
Brokerages have given Avantor, Inc. (NYSE:AVTR) an average "Hold" recommendation, with a one-year average price target of $11.80 based on ratings from sixteen analysts. Recent insider activity shows directors purchasing shares, indicating confidence, while institutional investors have adjusted their holdings. Avantor recently exceeded EPS and revenue estimates but saw a slight year-over-year revenue decrease, and has set its FY2026 EPS guidance.
AVTR Stock News Today | Earnings, Events & Price Alerts
This article provides recent news, events, and earnings analysis for Avantor (AVTR), including news about acquisition of shares, executive liability investigations, and options trading surges. It also highlights recent and upcoming earnings reports, showing a picture of the company's financial and legal landscape.
Avantor, Inc. Hits New 52-Week Low at $7.46 Amid Declining Stock Performance
Avantor, Inc. has reached a new 52-week low of $7.46, marking a significant 67.58% decline in its stock price over the past year. The company's financial metrics show struggles with profitability, including a P/E ratio of 18.00, a modest return on equity of 5.20%, and a 58.83% decrease in net profit to $79.98 million. These figures highlight the challenges Avantor faces in maintaining financial stability and growth in a competitive market.
Longleaf Partners Global Fund Increased Its Stake in Avantor (AVTR)
Longleaf Partners Global Fund increased its stake in Avantor, Inc. (AVTR) in the fourth quarter of 2025 despite the stock's underperformance, exiting the position by year-end after a leadership change and guidance reset. The fund's Q4 2025 investor letter highlighted that both Bio-Rad and Avantor negatively impacted its performance. While Avantor is not among the top 40 most popular stocks for hedge funds, the article suggests other AI stocks might offer greater upside and less downside risk.
Longleaf Partners Global Fund Increased Its Stake in Avantor (AVTR)
Longleaf Partners Global Fund, managed by Southeastern Asset Management, increased its stake in Avantor, Inc. (AVTR) during the fourth quarter of 2025. Despite this, the fund later decided to exit the position due to self-inflicted issues within Avantor and a leadership change. The article notes that Avantor is not among the 40 most popular stocks among hedge funds heading into 2026.
Is It Time To Reconsider Avantor (AVTR) After A 53% One Year Share Price Decline
Avantor's (AVTR) share price has declined by 53% over the past year, leading to a recent valuation analysis. A Discounted Cash Flow (DCF) model suggests the company is currently undervalued by 50.9%, with an estimated intrinsic value of $15.50 per share compared to its recent price of $7.61. Additionally, its Price-to-Sales (P/S) ratio of 0.79x is significantly below the industry average, further indicating it might be undervalued.
Is It Time To Reconsider Avantor (AVTR) After A 53% One Year Share Price Decline
Avantor (AVTR) has seen a significant 53% decline in its share price over the past year, prompting a reevaluation of its intrinsic value. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 50.9% at $7.61, indicating a fair value of around $15.50 per share. Additionally, its Price/Sales ratio of 0.79x is considerably lower than the industry average, further suggesting it may be undervalued.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Avantor, Inc. (NYSE:AVTR). The firm is encouraging investors who purchased Avantor securities prior to March 5, 2024, and continue to hold them, to come forward and learn more about the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis in securities fraud class actions.
Eversept Ups Avantor Stake As Revival Program And Valuation Draw Focus
Eversept Partners has increased its ownership stake in Avantor (NYSE:AVTR), coinciding with Avantor's "Revival" program aimed at addressing organic revenue declines and restructuring. This move places a spotlight on Avantor's management execution and communication, particularly concerning cost savings, growth trends, and debt management during its turnaround efforts. The company's shares are currently trading below analyst targets and Simply Wall St's fair value estimate.
Voss Capital LP Increases Stock Position in Avantor, Inc. $AVTR
Voss Capital LP significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 905.6% during the third quarter, acquiring an additional 4,075,000 shares, bringing its total to 4,525,000 shares valued at approximately $56.47 million. This makes Avantor Voss Capital's 12th largest holding. The article also notes recent insider buying, Avantor's current trading performance, revenue beats, and analyst ratings, which largely suggest a "Hold" with an average target price of $11.80.
Avantor, Inc. Hits New 52-Week Low at $7.58 Amidst Major Decline
Avantor, Inc. has reached a new 52-week low of $7.58, indicating significant financial challenges over the past year with its stock price dropping by 67.58%. The company is struggling with profitability, evidenced by low returns on equity and capital, alongside a substantial decline in net profit and operating cash flow. Its market capitalization stands at $6,159 million with a P/E ratio of 14.00, but underperformance continues to be a major concern for the specialty chemicals player.
12,793,957 Shares in Avantor, Inc. $AVTR Bought by London Co. of Virginia
London Co. of Virginia recently acquired a significant new stake of 12,793,957 shares in Avantor, Inc. (NYSE:AVTR) valued at approximately $159.7 million during the third quarter. This purchase makes London Co. of Virginia one of the largest institutional holders of Avantor stock. The article also details other hedge fund activities, insider purchases by Avantor directors totaling over $2.3 million, and recent financial performance and analyst ratings for the company.
Price-Driven Insight from (AVTR) for Rule-Based Strategy
This article provides a price-driven analysis for Avantor Inc. (AVTR) using AI models, suggesting a weak sentiment across all horizons and elevated downside risk. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report highlights support and resistance levels across near-term, mid-term, and long-term horizons, and offers real-time trading signals and personalized alerts to registered users.
